Author:
Tamene Fasil Bayafers,Mihiretie Endalamaw Aschale,Mulugeta Abiy,Kassaye Abenet,Gubae Kale,Wondm Samuel Agegnew
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Guze SB. Diagnostic and statistical manual of mental disorders, (DSM-IV). American Journal of Psychiatry. 1995;152(8):1228-.
2. Kahn R, Sommer I, Murray R, Meyer-Lindenberg A. Weinberger D. CannonT, et al.Schizophrenia Nat Rev Dis Primers. 2015;1:15067.
3. Effiong JH, Umoh KA. Medication non adherence in schizophrenia: Prevalence and correlates among outpatients in a tertiary healthcare facility in Uyo. South-South Nigeria Clin Med Diagn. 2015;5(6):107–13.
4. Deegan PE, Drake RE. Shared decision making and medication management in the recovery process. Psychiatr Serv. 2006;57(11):1636–9.
5. Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Mol Psychiatry. 2013;18(1):53–66.